Google Übersetzer
Marizyme, Inc.
About
0.00USD+0.00 +0.00%
Closed • Updated at 18:09 GMT+00:00Market Cap$131.793
Volume20.0K
Beta0.37
RSI41.82
Marizyme, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2024
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
Oct 23 2023
Marizyme CEO Delivers Business Update
Oct 6 2023
The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
Oct 6 2023
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
May 10 2023
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
Recent Videos
Qualigen's Big Deal: My Take on the Marizyme Loan
Aug 29, 2025
Marizyme; Discussing the Company's Recent Commercialization Updates & More
Nov 08, 2023
Marizyme Inc CEO releases corporate update including details of key progress on DuraGraft
Oct 26, 2023
Marizyme; Diving Deeper into the Company with the Investor Deck
Oct 25, 2023